Key Record Dates
ClinicalTrials.gov Identifier: | NCT00267748 |
---|---|
Brief Title: | Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC) |
First Submitted : | December 20, 2005 |
First Submitted that Met QC Criteria : | December 20, 2005 |
First Posted : | December 21, 2005 (Estimate) |
Results First Submitted : | June 23, 2011 |
Results First Submitted that Met QC Criteria : | August 3, 2011 |
Results First Posted : | September 5, 2011 (Estimate) |
Last Update Submitted that Met QC Criteria : | August 3, 2011 |
Last Update Posted : | September 5, 2011 (Estimate) |